Assessment of Biomarker Testing for Lung Cancer Screening Eligibility

This exploratory study analyzes the cost-effectiveness of incorporating biomarkers into eligibility assessment for lung screening.

Detalles Bibliográficos
Autores principales: Larose, Tricia L., Meheus, Filip, Brennan, Paul, Johansson, Mattias, Robbins, Hilary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059020/
https://www.ncbi.nlm.nih.gov/pubmed/32134462
http://dx.doi.org/10.1001/jamanetworkopen.2020.0409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059020/
https://www.ncbi.nlm.nih.gov/pubmed/32134462
http://dx.doi.org/10.1001/jamanetworkopen.2020.0409

Ejemplares similares